Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Motley Fool Money30 Heinä 2023

Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss drugs. - The challenge of selling lizard venom research to pharmaceutical companies. - What decades-old research on anglerfish reveals about modern side effects for Ozempic. - And why it’s “not too hard” to keep dozens of Gila Monsters in your basement. “Monster Diet Drugs Like Ozempic Started With Actual Monsters”: https://www.wsj.com/articles/ozempic-mounjaro-gila-monster-anglerfish-8c9c1ff2 Companies mentioned: NVO, LLY Host: Ricky Mulvey Guest: Rolfe Winkler Engineers: Tim Sparks, Heather Horton Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(2151)

A Couple’s Financial Manifesto, Revisited

A Couple’s Financial Manifesto, Revisited

It’s Valentine’s Day, and there’s nothing more romantic than talking about money with your partner. Well, maybe not. But it is important because studies show that financial acrimony can lead to marita...

14 Helmi 21min

The Week's Growth Wasn’t Enough For Wall Street

The Week's Growth Wasn’t Enough For Wall Street

We saw a rush of earnings reports this week and while results looked solid, stocks often cratered on fear of AI and disruption. We discuss our takeaways and where there may be value for investors. The...

13 Helmi 42min

Shopify’s Whiplash Day

Shopify’s Whiplash Day

It looked like Shopify’s stock was headed for a great day when it reported earnings, only for the stock to give up all its gains and then some when management started talking on the conference call. T...

12 Helmi 24min

Subscription Prices Are Going Up Again

Subscription Prices Are Going Up Again

Subscription prices are going up across the board and that may be the norm for the foreseeable future. Then we discuss the state of retail spending and why Unity’s stock dropped 30% on fear AI will di...

11 Helmi 16min

Rule Breaker Earnings Roundup

Rule Breaker Earnings Roundup

In today’s episode of Motley Fool Money, host Emily Flippen is joined by analysts Jason Hall and Toby Bordelon to break down earnings from three of the most volatile Rule-Breaking stocks out there. Th...

10 Helmi 23min

AI Capex Is Off the Charts: Who Stands to Lose?

AI Capex Is Off the Charts: Who Stands to Lose?

Big Tech spending on equipment and AI appears to be close to $400 billion over the four quarters alone. Are there losers outside the free-spending tech titans? Jason Hall and Travis Hoium join Tim Bey...

9 Helmi 26min

2 Go-To Market Indicators, 6 Stock Ideas for the Next 5 Years

2 Go-To Market Indicators, 6 Stock Ideas for the Next 5 Years

Motley Fool co-founder and CEO Tom Gardner talks about separating AI contenders from pretenders, his two favorite market indicators, and lessons from the dot-com bubble. Plus, Tom shares six stock ide...

8 Helmi 24min

Take Control of Your Cash Flow, and Energy Stocks on Fire

Take Control of Your Cash Flow, and Energy Stocks on Fire

Certified Financial Planner Stephanie Marini joins Robert Brokamp for this month’s installment of the 2026 Financial Planning Challenge. Stephanie and Bro (Robert’s nickname at The Motley Fool) explai...

7 Helmi 21min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
ostan-asuntoja-podcast
herrasmieshakkerit
rss-seuraava-potilas
rahapuhetta
rss-rahamania
rss-40-ajatusta-aanesta
rss-porssipuhetta
rss-merja-mahkan-rahat
rss-lahtijat
rss-20-30-40-podcast
rss-levosta-kasin-yrittajyys
rss-draivi
rss-ma
raksapodi
rss-laakispodi
rss-paasipodi